[Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang
Xiao-hong
XH
Department of Diagnostic Radiology, Cancer Hospital, Fudan University, Shanghai 200032, China.
Peng
Wei-jun
WJ
Xin
Chao
C
Tan
Hong-na
HN
Gu
Ya-jia
YJ
Tang
Feng
F
Mao
Jian
J
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016190:Carboplatin / Q000008:administration & dosage; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003287:Contrast Media; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018365:Neoplasm, Residual; D017239:Paclitaxel / Q000008:administration & dosage
D003287:Contrast Media; D016190:Carboplatin; D017239:Paclitaxel